Leaflet PANDERM ointment
Indicated for: inflammatory dermatoses with bacterial or fungal infection
Route of administration: cutaneous
Substance: clobetasol + neomycin + nystatin (potent corticosteroid, aminoglycoside antibiotic and polyene antifungal)
ATC: D07CB01 (Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, moderately potent, combinations with antibiotics)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine may increase blood sugar.
This medicine may increase the risk of infections.
This medicine may affect the kidneys.
This medicine may affect hearing or balance.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Clobetasol + neomycin + nystatin is a skin combination used in selected severe or recurrent inflammatory skin conditions when a doctor also suspects a bacterial or fungal component. Clobetasol is a very potent corticosteroid, neomycin is an antibiotic, and nystatin is an antifungal mainly active against Candida. This product should be used only on prescription.
Apply a thin layer to the affected area, usually for short periods, exactly as directed. Do not use it on large areas, under occlusive dressings, on the face, eyelids, genital area or broken skin unless clearly advised. Wash hands after application unless the hands are being treated. Do not extend treatment simply because itching returns.
Possible side effects include burning, stinging, irritation, thinning of the skin, stretch marks, acne, skin colour changes, increased local hair growth or worsening infection. Neomycin may cause contact allergy, and excessive corticosteroid use can lead to systemic absorption, especially in children or on damaged skin. Viral infections such as herpes may worsen.
Contact the doctor if the lesion spreads, pus, severe pain, fever, allergic reaction, facial swelling or no improvement after a few days occurs. Do not use it for ordinary acne, rosacea, perioral dermatitis, chickenpox or untreated infections without medical advice. Treatment should be reviewed if repeated or prolonged courses are needed.
General data about PANDERM
- Substance: clobetasol + neomycin + nystatin
- Date of last drug list: 01-07-2015
- Commercial code: W51640001
- Pharmaceutical form: ointment
- Quantity: 1
- Product type: generic
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).